Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US01438T1060
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG0029H8ZF6
ALDX
Aldeyra Therapeutics Inc
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Aldeyra Therapeutics Inc
ISIN
US01438T1060
TICKER
ALDX
MIC
XNAS
REUTERS
ALDX.OQ
BLOOMBERG
ALDX US
Sun, 26.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 24.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securities...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.04.2026       Aldeyra Therapeutics
US01438T1060

Key Dates and Disclosure Events Shareholders Need to KnowNEW YORK, April 23, 2026 /PRNewswire/ -- SueWallSt encourages investors who suffered losses in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) to contact the firm. WHO IS AFFECTED: Those who purchased ALDX securities between November 3, 2023 and March 16, 2026 may be entitled to recover damages. F...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.04.2026       Aldeyra Therapeutics
US01438T1060

If you have suffered a loss on your Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ:ALDX) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have u...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       Aldeyra Therapeutics
US01438T1060

Executive Accountability: Michael Alferi Named in Securities ActionNEW YORK, April 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors that Michael Alferi, Head of Finance, principal financial officer, and principal accounting officer of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), is named as an individual defendant in a securitie...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Aldeyra Therapeutics
US01438T1060

Levi & Korsinsky, LLP notifies investors that Michael Alferi, Head of Finance, principal financial officer, and principal accounting officer of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), is named as an individual defendant in a securities class action covering purchases between November 3, 2023 and March 16, 2026. Find out if you can recover l...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 21.04.2026       Aldeyra Therapeutics
US01438T1060

NEW YORK, April 21, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX). Shareholders who purchased shares of ALDX during the class period listed are encoura...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.04.2026       Aldeyra Therapeutics
US01438T1060

NEW YORK, April 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inc...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Aldeyra Therapeutics
US01438T1060

LOS ANGELES, April 20, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. ("Aldeyra" or "the Company") (NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Sha...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 19, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securities...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sun, 19.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sun, 19.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sat, 18.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securities...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 17.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 16.04.2026       Aldeyra Therapeutics
US01438T1060

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ: ALDX).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Aldeyra Therapeutics
US01438T1060

Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRANEW YORK, April 16, 2026 /PRNewswire/ -- IMPORTANT DATE: May 29, 2026. Investors who purchased Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026 and wish to seek appointment as lead plaintiff must file a motion by this date. Start y...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Aldeyra Therapeutics
US01438T1060

SAN DIEGO, April 15, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026. Defendant Aldeyra describes itself as "biotechnology company devoted to discovering...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.04.2026       Aldeyra Therapeutics
US01438T1060

NEW YORK, April 15, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inc...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.04.2026       Aldeyra Therapeutics
US01438T1060

Key Dates and Disclosure Events Shareholders Need to KnowNEW YORK, April 15, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP encourages investors who suffered losses in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) to contact the firm. WHO IS AFFECTED: Those who purchased ALDX securities between November 3, 2023 and March 16, 2026 may be entitled to re...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 14.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 14, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 14.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sun, 12.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 12, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sun, 12.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sat, 11.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 11, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sat, 11.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.04.2026       Aldeyra Therapeutics
US01438T1060

NEW YORK, April 10, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inc...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 10, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securi...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.04.2026       Aldeyra Therapeutics
US01438T1060

NEW YORK, April 9, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ: ALDX).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-m...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securit...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Wed, 08.04.2026       Aldeyra Therapeutics
US01438T1060

NEW YORK, April 7, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.04.2026       Aldeyra Therapeutics
US01438T1060

Lead Plaintiff Deadline is May 29, 2026NEW YORK, April 7, 2026 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP informs investors that a securities fraud class action lawsuit has been filed against Aldeyra Therapeutics, Inc., ("Aldeyra" or the "Company") (NASDAQ: ALDX)   on behalf of investors that bought securities between November 3...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.04.2026       Aldeyra Therapeutics
US01438T1060

NEW YORK, April 7, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX). Shareholders who purchased shares of ALDX during the class period listed are encourag...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Tue, 07.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 6, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"). A class action lawsuit...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Mon, 06.04.2026       Aldeyra Therapeutics
US01438T1060

LOS ANGELES, April 6, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. ("Aldeyra" or "the Company") (NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shar...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sun, 05.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Jo...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Sat, 04.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"). A class action la...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 03.04.2026       Aldeyra Therapeutics
US01438T1060

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner J...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Fri, 03.04.2026       Aldeyra Therapeutics
US01438T1060

LOS ANGELES, April 3, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. ("Aldeyra" or "the Company") (NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shar...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.04.2026       Aldeyra Therapeutics
US01438T1060

SAN DIEGO, April 2, 2026 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026. Defendant Aldeyra describes itself as "biotechnology company devoted to discovering...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.04.2026       Aldeyra Therapeutics
US01438T1060

New York, New York--(Newsfile Corp. - April 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"). A class action lawsuit...
Read more
Aldeyra Therapeutics
Technical Analysis Termsheets Terminal
Permalink